Precision Medicine in Internal Medicine.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
07 05 2019
Historique:
pubmed: 30 4 2019
medline: 14 1 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

Medicine has long sought to match diagnostic and treatment approaches to the particular needs and risks of individual patients. The decreasing cost and increasing ease of genetic sequencing have propelled the rise of precision medicine. Precision medicine aims to use genetic and other information to provide care tailored to the individual patient, with the goal of improving clinical outcomes and minimizing unnecessary diagnostic and therapeutic interventions. Although developments in genetic sequencing have the potential to transform clinical care, there are important limitations, including uncertainty in the clinical interpretation of many genetic variants and concerns about privacy, discrimination, and cost. To help clinicians understand the basics of genetic sequencing and how to apply it in clinical practice, Annals of Internal Medicine is launching a new "Precision Medicine" series. This introduction provides a general overview of clinical sequencing, with a focus on germline variation. Subsequent articles will use a case-based format to provide concise summaries of specific clinical precision medicine scenarios that are relevant to the practice of internal medicine. These cases will highlight specific clinical indications; interpretation of genetic test results; and ethical, legal, cost, and privacy issues related to genetic testing. The goal is to provide practical information on the appropriate application and interpretation of genomics in routine clinical practice.

Identifiants

pubmed: 31035290
pii: 2732074
doi: 10.7326/M18-0425
pmc: PMC7437606
mid: NIHMS1615351
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

635-642

Subventions

Organisme : NIDDK NIH HHS
ID : UH3 DK114926
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG008680
Pays : United States
Organisme : NIDDK NIH HHS
ID : UG3 DK114926
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001873
Pays : United States
Organisme : NIH HHS
ID : UG3 OD023183
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Am J Hum Genet. 2018 Jul 5;103(1):58-73
pubmed: 29961570
Healthcare (Basel). 2015;3(3):830-7
pubmed: 26636032
N Engl J Med. 2019 Jan 10;380(2):142-151
pubmed: 30586318
Atherosclerosis. 2016 Dec;255:128-139
pubmed: 27839699
Genet Med. 2017 May;19(5):606
pubmed: 28492529
Cell. 2018 Jun 14;173(7):1692-1704.e11
pubmed: 29779949
Obstet Gynecol. 2017 Mar;129(3):e41-e55
pubmed: 28225426
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nature. 2014 Apr 24;508(7497):469-76
pubmed: 24759409
Genet Med. 2013 Jun;15(6):482-3
pubmed: 23619275
N Engl J Med. 2013 Oct 17;369(16):1502-11
pubmed: 24088041
J Clin Oncol. 2015 Nov 1;33(31):3660-7
pubmed: 26324357
Genome Med. 2015 Jun 13;7(1):54
pubmed: 26195989
Genet Med. 2013 Jul;15(7):565-74
pubmed: 23788249
Science. 2018 Mar 16;359(6381):1233-1239
pubmed: 29590070
Prenat Diagn. 2015 Oct;35(10):931-5
pubmed: 26138560
Eur Heart J. 2014 Aug 21;35(32):2146-57
pubmed: 25053660
Am J Hum Genet. 2012 Jul 13;91(1):97-108
pubmed: 22703879
Nature. 2017 Aug 17;548(7667):297-303
pubmed: 28783718
Hum Genet. 2011 Apr;129(4):351-70
pubmed: 21331778
JAMA. 2016 Aug 16;316(7):734-42
pubmed: 27533158
Genet Med. 2015 Jan;17(1):70-87
pubmed: 25394175
Ann Intern Med. 2018 Jan 16;168(2):100-109
pubmed: 29204651
Genet Med. 2016 Jul;18(7):696-704
pubmed: 26633542
Genet Med. 2019 May;21(5):1100-1110
pubmed: 30287922
Br J Haematol. 2010 Apr;149(2):209-20
pubmed: 20128794
Ann Intern Med. 2019 Jan 1;170(1):11-21
pubmed: 30476936
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
N Engl J Med. 2017 Jan 5;376(1):21-31
pubmed: 27959697
Hum Mutat. 2010 Jun;31(6):631-55
pubmed: 20506564
Gastroenterology. 2014 Aug;147(2):502-26
pubmed: 25043945
JAMA. 2014 Nov 12;312(18):1880-7
pubmed: 25326637
Nat Rev Nephrol. 2018 Feb;14(2):83-104
pubmed: 29307893
Nat Rev Genet. 2013 Oct;14(10):681-91
pubmed: 23999272
Genet Med. 2017 Feb;19(2):249-255
pubmed: 27854360

Auteurs

Krzysztof Kiryluk (K)

College of Physicians and Surgeons, Columbia University, New York, New York (K.K., D.B.G., A.G.G., R.W., W.K.C.).

David B Goldstein (DB)

College of Physicians and Surgeons, Columbia University, New York, New York (K.K., D.B.G., A.G.G., R.W., W.K.C.).

John W Rowe (JW)

Mailman School of Public Health, Columbia University, New York, New York (J.W.R.).

Ali G Gharavi (AG)

College of Physicians and Surgeons, Columbia University, New York, New York (K.K., D.B.G., A.G.G., R.W., W.K.C.).

Ronald Wapner (R)

College of Physicians and Surgeons, Columbia University, New York, New York (K.K., D.B.G., A.G.G., R.W., W.K.C.).

Wendy K Chung (WK)

College of Physicians and Surgeons, Columbia University, New York, New York (K.K., D.B.G., A.G.G., R.W., W.K.C.).

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH